ProfileGDS5678 / 1421842_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 19% 21% 19% 60% 20% 18% 18% 20% 20% 34% 20% 20% 19% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4828619
GSM967853U87-EV human glioblastoma xenograft - Control 22.4902921
GSM967854U87-EV human glioblastoma xenograft - Control 32.4636619
GSM967855U87-EV human glioblastoma xenograft - Control 43.5478660
GSM967856U87-EV human glioblastoma xenograft - Control 52.4293820
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4936818
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4645718
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4531720
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4487820
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.7501234
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4594920
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4508220
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4596619
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4311718